Welcome to Global Regulatory MedDev
Your Trusted Partner in Global Regulatory Strategy
GR MedDev empowers executives, startups, and innovators with customized solutions that accelerate market entry, build regulatory confidence, and drive sustainable growth in highly regulated industries, providing deep expertise across medical devices, in vitro diagnostics (IVD), Software as a Medical Device (SaMD), Software in a Medical Device (SiMD), clinical operations, pharmaceuticals, biologics, GxP compliance, and AI‑enabled technologies. Specialized in audit and QMS compliance under MDSAP, ISO 13485, EU MDR 2017/745, EU IVDR 2017/746, 21 CFR Parts 210/211, 212, 820, GMP, and GxP.
Global Regulatory MedDev's Mission
Our mission is to help your products achieve the highest standards of safety, performance, and compliance with key global regulations such as MDR 2017/745, IVDR 2017/746, UK MDR, 21 CFR 820, and 21 CFR 11—paving the way for seamless CE marking and FDA approvals.
GR MedDev's Expertise
At GR MedDev, our expertise spans the full spectrum of regulatory compliance, Quality Management System (QMS) assessments, and clinical trial oversight—including advanced domains such as Software as a Medical Device (SaMD) with integrated AI capabilities. We deliver comprehensive QMS gap analyses and rigorous compliance audits designed to ensure your operations not only meet but consistently exceed international standards.
We specialize in performing compliance audits that evaluate both performance and adherence to key global regulations, including MDR (EU 2017/745), IVDR (EU 2017/746), UK MDR, 21 CFR 820, 21 CFR 11, and MDSAP (Medical Device Single Audit Program). These audits pave the way for seamless CE marking, FDA approvals, and multi-jurisdictional market access, ensuring readiness across the EU, UK, US, Canada, Brazil, Japan, and Australia. Our services also include deep gap assessments of MDR and IVDR requirements, QMSR alignment, and targeted remediation training, equipping organizations with the tools to close compliance gaps effectively.
Beyond regulatory audits, we conduct advanced QMS reviews in accordance with ISO/IEC 42001, 27001, and 27701, while also addressing emerging frameworks such as the EU AI Act, NIST Risk Management Framework, and Canada’s AIDA. For diagnostic and testing laboratories, our consulting expertise emphasizes robust QMS implementation aligned with ISO 15189 and ISO 17025, supporting in-house testing, biocompatibility assessments, and ASCA accreditation.
To further strengthen organizational resilience, we provide specialized training in Human Factors Engineering and Usability Engineering, ensuring that product design and testing meet both regulatory expectations and user-centered safety standards. This holistic approach empowers healthcare, pharmaceutical, and life sciences organizations to achieve recognized compliance, operational excellence, and sustainable innovation.
Services Provided By Global Regulatory MedDev
Partner with Global Regulatory MedDev to gain the clarity, confidence, and compliance assurance necessary to thrive in today’s demanding regulatory environment.
Frequently Asked Questions
When should I start planning for regulatory approval of my product?
Regulatory considerations should begin at the initial stages of product development. Early integration of a regulatory strategy helps you avoid costly redesigns, meet critical timelines, and control expenses. Compliance isn’t an afterthought—it should be built into your product design from the ground up.
How can I tell if my product is regulated as a medical device or an in vitro diagnostic (IVD)?
This depends mainly on your product’s intended use and its declared medical purpose. We carefully review your specific case to determine if Regulation (EU) 2017/745 (MDR) or Regulation (EU) 2017/746 (IVDR) applies—or if your product might fall outside these regulatory frameworks.
What are the steps to obtain CE marking?
The essential stages include:
• Classifying your product correctly
• Implementing a suitable Quality Management System (e.g., ISO 13485 where applicable)
• Conducting clinical or performance evaluations
• Preparing a thorough technical documentation file
• Engaging with a Notified Body when required We guide you at every step to ensure a smooth path to CE certification.
How is medical software regulated?
Software with medical functionalities, such as diagnosis or treatment, qualifies as Software as a Medical Device (SaMD). We assist you in addressing key regulatory requirements, including:
• Product classification
• Clinical validation
• Cybersecurity measures
• Compliance with lifecycle standards like IEC 62304
• Integration of Artificial Intelligence components, if applicable
When is a clinical trial necessary?
Clinical trials are needed when existing published evidence is insufficient or when your product poses notable clinical risks. We can help you determine the necessity, design, and regulatory-compliant execution of clinical trials.
What is a Notified Body?
A Notified Body is an independent organization authorized to audit medium- to high-risk medical devices. Products classified as Class IIa, IIb, or III require such assessments. We prepare you thoroughly to meet the expectations of these audits.
What’s the difference between CE marking and FDA approval?
• CE (Europe): Emphasizes a clinical evidence-based approach and allows design flexibility.
• FDA (USA): Generally, more prescriptive but offers expedited pathways for eligible products. We help you develop regulatory strategies that align with both markets, running in parallel to optimize your product’s global access.
Can I launch a Minimum Viable Product (MVP) without regulatory approval?
If your product is intended for medical use, regulatory compliance is mandatory before it can be marketed or used with patients. We collaborate with you to craft a staged validation roadmap, covering technical, clinical, and regulatory milestones.
What is Post-Marketing Surveillance (PMS)?
PMS is the ongoing monitoring required once your product is on the market. Key components include:
• A comprehensive Post-Market Surveillance Plan (PMSP)
• Post-Market Clinical Follow-up (PMCF) studies
• Incident reporting and management. We assist you in maintaining regulatory compliance through effective PMS programs that support both CE marking and FDA requirements.
What are the risks of non-compliance with regulations?
Failing to comply puts patient safety, your company’s reputation, and market access at serious risk. Non-compliance can lead to sanctions, legal action, or costly product recalls. Investing in compliance early is a strategic move that safeguards both your business and your customers.
If you have specific questions about your situation,
let’s connect.
GR MedDev is ready to guide you through the regulatory journey with clarity and assurance.
GR MedDev
Partner with Global Regulatory MedDev to gain clarity, confidence, and compliance assurance necessary to thrive in today’s demanding regulatory environment.
© Copyright Global Regulatory MedDev | All Rights Reserved | Privacy Policy | Cookie Policy | Terms of Service